Wednesday, January 04, 2012
The In Vivo Blog's deals of the year, as chosen by our readers, are:
Alliance of the Year goes to Forma/Genentech, with nearly 47% of the vote,. The deal jumped out to an early lead and hung on, despite a last minute surge from AZ/Healthcore (20%) and the late entry from Abbott/Reata II (14%). Congratulations!
M&A of the Year was won by Sanofi/Genzyme, with about 29% of the vote. Oddly the M&A category, normally one that draws a lot of interest, had fewer votes than the others this year. Our runner up was Gilead/Pharmasset (24%), followed by Abbott/Abbott Pharma (19%).
Exit/Financing of the Year goes to Quanticel, with 45% of the vote. In second place was Arteus (23%), and in third BMS/Amira (20%).
Congratulations to our winners (to collect your prize, click CTRL-P and cut out the picture, then tape it to your office door [paper and tape not included in prize, some restrictions may apply]), and as in years past if any of them would like to make an 'acceptance speech' here on the blog, please let us know.
Finally, thanks to our readers who cast votes.You can see all the final tallies here. Hope to see many of you next week in San Francisco. Happy New Year from all of us at IVB/EBI.